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Abstract objective Over time, we have seen a major evolution of measurement initiatives, indicators and
methods, such that today a wide range of maternal and perinatal indicators are monitored and new
indicators are under development. Monitoring global progress in maternal and newborn health outcomes
and development has been dominated in recent decades by efforts to set, measure and achieve global
goals and targets: the Millennium Development Goals followed by the Sustainable Development Goals.
This paper aims to review, reflect and learn on accelerated progress towards global goals and events,
including universal health coverage, and better tracking of maternal and newborn health outcomes.
methods We searched for literature of key events and global initiatives over recent decades related
to maternal and newborn health. The searches were conducted using PubMed/MEDLINE and the
World Health Organization Global Index Medicus.
results This paper describes global key events and initiatives over recent decades showing how
maternal and neonatal mortality and morbidity, and stillbirths, have been viewed, when they have
achieved higher priority on the global agenda, and how they have been measured, monitored and
reported. Despite substantial improvements, the enormous maternal and newborn health disparities that
persist within and between countries indicate the urgent need to renew the focus on reducing inequities.
conclusion The review has featured the long story of the progress in monitoring improving
maternal and newborn health outcomes, but has also underlined current gaps and significant
inequities. The many global initiatives described in this paper have highlighted the magnitude of the
problems and have built the political momentum over the years for effectively addressing maternal
and newborn health and well-being, with particular focus on improved measurement and monitoring.
keywords maternal mortality, maternal morbidity, neonatal mortality, neonatal morbidity,
stillbirths, monitoring, measurement, indicators, global initiatives, MMR, NMR, SBR
Introduction
Every day, approximately 810 women die from pre-
ventable causes related to pregnancy and childbirth [1],
almost 7000 newborns die [2] and more than 7000
babies are stillborn [3], based on the latest annual esti-
mates. The vast majority of these deaths occur in low-
and middle-income countries (LMICs). The burden of
maternal and newborn morbidity remains more difficult
to quantify (see definitions in Box 1). Over time, we have
seen a major evolution of measurement initiatives, indica-
tors and methods, such that monitoring efforts today use
a wide range of maternal and perinatal indicators, and
new indicators are under development, including indica-
tors for morbidity (see Box 2).
The growth of the world’s population, from under 2
billion 100 years ago to approximately 7.5 billion now
[17], clearly reflects significant improvements in global
health – especially child survival – raising life expectan-
cies. But when the rate of world population growth
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peaked in the 1960s, it began to cause alarm, prompting
re-assessments of global development and intensified
efforts to monitor international population dynamics.
This brought to light gaping disparities in mortality rates
between regions and populations.
By this time, maternal mortality in higher-income coun-
tries had been measured over many decades, with high
rates beginning to fall in the 1930s, converging at a mater-
nal mortality ratio (MMR) of around 60 per 100,000 live
births in 1960 [18]. But MMR gains in lower-income
countries have lagged far behind [1], despite progress in
health care and a halving of the global total fertility rate
from 5 in 1950–1960 to approximately 2.5 currently [19].
By 2000, when the MMR was estimated at 16 versus 378,
in more versus less developed regions [1], this was recog-
nised as the largest disparity in any mortality between
higher- and lower-income countries [18].
Monitoring of global progress in health and develop-
ment has been dominated since before the turn of the
millennium by efforts to set, measure and achieve global
goals and targets: first the Millennium Development
Goals (MDGs; 1990–2015) and subsequently the Sustain-
able Development Goals (SDGs; 2016–2030). Maternal
health and child health were the focus of two of the eight
MDGs (MDGs 4 and 5), and they are currently addressed
under SDG3 on health and well-being.
Table 1 presents the relevant MDG and SDG targets
and summarises MDG-era progress. By 2015, the 44%
Box 1 Definitions of terms
Maternal death: Death of a woman while pregnant or within 42 days of termination of pregnancy, irrespective of
the duration and the site of the pregnancy, from any cause related to or aggravated by the pregnancy or its manage-
ment, but not from accidental or incidental causes [4].
Maternal morbidity: Any health condition attributed to and/or complicating pregnancy and childbirth that has a
negative impact on the woman’s well-being and/or functioning [5].
Maternal near miss (MNM): A woman who nearly died but survived a complication that occurred during preg-
nancy, childbirth or within 42 days of termination of pregnancy [6].
Neonatal death: A death that occurs during the neonatal period – the first 28 days of life.
• Late neonatal death: A death that occurs in the late neonatal period (days 8–28).
• Early neonatal death: A death that occurs in the early neonatal period (days 1–7) [7].
Neonatal morbidity: No standard definition exists; there is ongoing work in this area.
Perinatal death: A death that occurs in the antepartum (before the onset of labour), intrapartum (during labour
but before delivery) or early neonatal period (days 1–7); the definition may also be extended to refer to deaths
throughout the neonatal period (days 1–28) [7,8].
Pre-term birth: Babies born alive before 37 weeks of pregnancy are completed.
• Moderate to late pre-term: 32 to < 37 weeks.
• Very pre-term: 28 to < 32 weeks.
• Extremely pre-term: < 28 weeks [9].
Pregnancy-related death, also known as a death occurring during pregnancy, childbirth and puerperium: The death
of a woman while pregnant or within 42 days of termination of pregnancy, irrespective of the cause of death
(obstetric and non-obstetric) [10].
Reproductive health: A state of complete physical, mental and social well-being and not merely the absence of dis-
ease or infirmity, in all matters relating to the reproductive system and to its functions and processes [11].
Stillbirth or foetal death:
A foetal death or stillbirth is defined as a baby born with no signs of life after a specified threshold [12]. For inter-
national comparison, WHO defines a stillbirth according to the 10th edition of the International Classification of
Diseases (ICD-10) definition of late foetal death (see below).
• Intrapartum (or fresh) foetal death (or stillbirth): Occurring after the onset of labour and before birth [7].
• Antepartum (or macerated) foetal death (or stillbirth): Occurring before the onset of labour [7].
• Late foetal death: A foetal death weighing at least 1000 g, or (if the birthweight is not available) a gestational
age of 28 completed weeks or more, or a crown–heel length of 35 cm or more (ICD-10 definition) [7,12].
• Early foetal death: A foetal death weighing at least 500 g, or (if birthweight is not available) a gestational age of
22 completed weeks or more, or a crown–heel length of 25 cm or more (ICD-10 definition) [7,12].
© 2019 World Health Organization. Tropical Medicine & International Health Published by John Wiley & Sons Ltd. 1343
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Box 2 Relevant indicators*
A. MORTALITY
Maternal:
• Maternal mortality ratio (MMR) – Number of maternal deaths during a given time period per 100,000 live births
during the same time period [1].
• Institutional maternal mortality ratio – Number of maternal deaths among 100,000 deliveries in health facilities/
institutions [13].
• Maternal mortality rate (MMRate) – The MMRate ‘is found by dividing the average annual number of maternal
deaths in a population by the average number of women of reproductive age (typically those aged 15 to 49 years)
who are alive during the observation period. Thus, the MMRate reflects not only the risk of maternal death per
pregnancy or per birth, but also the level of fertility in a population’ [14].
• Adult lifetime risk of maternal death – The probability that a 15-year-old girl will die eventually from a maternal
cause [1,14].
• The proportion of deaths among women of reproductive age that are due to maternal causes (PM) – The number
of maternal deaths in a given time period divided by the total deaths among women aged 15–49 years [1].
Neonatal/child:
• Neonatal mortality rate (NMR) – Probability that a child born in a specific year or period will die in the first
28 days of life (0–27 days) if subject to age-specific mortality rates of that period, expressed per 1000 live births
[13].
• Under-five mortality rate (U5MR) – The probability of a child born in a specific year or period dying before
reaching the age of 5 years, if subject to age-specific mortality rates of that period, expressed per 1000 live births
[13]. (Neonatal deaths make up a portion of this.)
• Infant mortality rate (IMR) – The probability that a child born in a specific year or period will die before reach-
ing the age of 1 year, if subject to age-specific mortality rates of that period, expressed as a rate per 1000 live
births [13]. (Neonatal deaths make up a portion of this.)
Stillbirths:
• Stillbirth rate (SBR) – Number of stillbirths per 1000 total births. Stillbirths can occur antepartum or intra-
partum. In many cases, stillbirths reflect inadequacies in antenatal care coverage or in intrapartum care. For pur-
poses of international comparison, stillbirths are defined as third trimester foetal deaths (≥ 1000 g or ≥ 28 weeks)
[13].
B. MORBIDITY
Maternal:
• Maternal morbidity rate or ratio – No indicator exists; there is ongoing research in this area.
• Maternal near miss (MNM) incidence ratio – Number of MNM cases per 1000 live births [6].
• Severe systemic infection/sepsis in the post-natal period (%) – Percentage of women in health facilities with severe
systemic infection/sepsis in the post-natal period, including readmissions (after birth in a facility) [13].
Neonatal:
• Neonatal morbidity rate or ratio – No indicator exists; there is ongoing research in this area.
• Incidence of low birthweight among newborns – Percentage of live births that weigh less than 2500 g [13].
• Pre-term birth rate – All live births before 37 completed weeks (whether singleton or multiple) per 100 live births
[9].
• Newborns receiving essential newborn care – Percentage of newborns who received all four elements of essential
newborn care: immediate and thorough drying, immediate skin-to-skin contact, delayed cord clamping and initia-
tion of breastfeeding in the first hour [13].
• Treatment for neonatal sepsis – Newborns with suspected severe bacterial infection who receive appropriate
antibiotic therapy [13].
1344 © 2019 World Health Organization. Tropical Medicine & International Health Published by John Wiley & Sons Ltd.
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decline in global MMR had missed the ambitious tar-
get of 75%, and MMR was still almost 20 times
higher in low- versus high-income countries [20]. The
SDG target to reduce the global MMR below 70 by
2030 presents a serious challenge. Based on the latest
available evidence from a 2014 WHO systematic analy-
sis of global data on causes of maternal death for
2003 to 2009, 72.5% of 2,443,000 maternal deaths
were due to direct obstetric causes (haemorrhage
27.1%, hypertension 14.0%, sepsis 10.7%, abortion
7.9%, embolism 3.2%, other 9.6%), and 27.5% were
due to indirect causes (HIV-related 5.5%, pre-existing
medical condition 14.8%, other 7.2%) [21]. Mean-
while, the under-five mortality rate (U5MR) was
reduced by 55% worldwide, falling short of the MDG
target to reduce it by two-thirds [2]. The global neona-
tal mortality rate (NMR) fell by 48% in the same per-
iod, to 19.1 per 1000 live births, although there was
no MDG target [2]. Focusing on newborns will be
critical to further reductions in child mortality, given
that in 2015 almost half (47%) of under-five deaths
were neonatal deaths [2]. The SDG target is an NMR
in all countries of 12 or fewer. Based on global data
for 2017, neonatal deaths are caused mainly by
complications of prematurity (34%), intrapartum condi-
tions (24%) and infections (20%), notably sepsis
and acute respiratory infection [22,23]. Stillbirths have
not been addressed by the MDGs or the SDGs, but
the stillbirth rate (SBR) declined by 25.5% between 2000
and 2015 to 18.4 stillbirths per 1000 total births [12]. A
target stated in the 2014 Every Newborn Action Plan is
for all countries to reach an SBR of 12 or fewer by 2030
[24]. Most stillbirths are caused by ‘preventable conditions
such as maternal infections (notably syphilis and malaria),
non-communicable diseases and obstetric complications.
Few are due to congenital disorders, but some of these are
also preventable’ [25].
The aim of this review was to support reflection and
learning for accelerated progress and better tracking of
maternal and newborn health outcomes, as well as pro-
gress towards the SDGs and universal health coverage.
This review takes a global perspective, describing key glo-
bal events and initiatives over recent decades to show how
maternal and neonatal mortality – and, more recently,
morbidity, as well as stillbirths – have been viewed, when
they have achieved higher priority on the global health
and development agenda, and how they have been mea-
sured, monitored and reported. The timeline presented in
C. OTHER (Relevant to both mortality and morbidity)
Maternal:
• Antenatal care coverage – Percentage of women aged 1549 years with a live birth in a given time period who
received antenatal care, four times or more times from any provider [13,15].
• Post-partum care coverage – women – Percentage of women who have post-partum contact with a health provi-
der within two days of delivery [13,15].
• Maternal death review coverage (%) – Percentage of maternal deaths occurring in the facility that were audited
and reviewed [13].
• Proportion of women in antenatal care who were screened for syphilis during pregnancy [15].
Neonatal:
• Post-natal care coverage – newborn – Proportion of newborns who have a post-natal contact with a health provi-
der within two days of delivery [13,15].
• Neonatal death review coverage (%) – Percentage of neonatal deaths occurring in the facility that were audited
[13].
• Proportion of infants who were breastfed within the first hour of birth [15].
Childbirth/delivery:
• Births attended by skilled health personnel – Percentage of live births attended by skilled health personnel during
a specified time period [13].
• Institutional delivery coverage – Proportion of women who gave birth in a health institution (number of deliveries
in institutions among total deliveries) [13].
• Caesarean section rate – Percentage of deliveries by caesarean section [13].
*For further analysis of maternal and newborn indicators, please see Moller et al., 2018 [16].
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Figure 1 summarises these global initiatives. In addition,
this review includes recommendations for accelerated
action to achieve global goals and targets.
Measuring, monitoring and prioritising maternal and
perinatal mortality
Establishment of the United Nations: global concern for
maternal and child health
International recognition of maternal mortality as a
critical issue began with the League of Nations, the
forerunner to the UN, which was created in 1919 [28].
As reported by AbouZahr [29], ‘The League of
Nations Health Section noted concerns about maternal
mortality in 1930, reflecting the increasing interest in
the topic in industrialised countries and the desire of
many colonial powers to transfer to their colonies the
benefits of medical progress that were by now so
apparent’. The UN was established in 1945, and the
League of Nations Health Organization became the
World Health Organization (WHO). WHO’s Constitu-
tion entered into force in 1948, with one of its func-
tions being ‘to promote maternal and child health and
welfare’ [30].
World conferences on population: early awareness, good
intentions
Reflecting international concern about population growth
since the 1960s, the UN has led three world conferences
on population: in 1974 in Bucharest, Romania; in 1984
in Mexico City, Mexico; and in 1994 in Cairo, Egypt.
While population, development and fertility were the
focus of the World Population Plan of Action (WPPA –
prepared by the UN Population Division [UNPD] before
the first conference), one of the stated goals was to
reduce mortality levels, particularly infant and maternal
mortality levels, to the maximum extent possible in all
regions of the world and to reduce national and sub-na-
tional differentials therein’; reduction of related maternal
morbidity was also mentioned as requiring vigorous
efforts. The WPPA stated clear international targets,
including ‘countries with the highest mortality levels
should aim by 1985 to have an expectation of life at
birth of at least 50 years and an infant mortality rate of
less than 120 per thousand live births’ [31]. These and
other statements highlighted – in the early 1970s – the
need to improve maternal and child health (MCH), to
reduce mortality and morbidity, and to reduce disparities
between higher- and lower-income regions. At the 1984
1970 1974 1978 1980 1984 1987 1990 1992 1994 1995 2000 2001 2002 2003 2004 2005 2007 2008 2010 2011 2012 2014 2015 2016 2018 2020
International 
Conference 
on Population, 
Mexico City
Safe 
Motherhood 
Conference 
(Safe 
Motherhood 
Initiative), 
Nairobi
International 
Conference on 
Population and 
Development 
(ICPD) 
(Programme of 
Action/PoA), Cairo
World Summit for 
Children (World 
Declaration on the 
Survival, Protection 
and Development of 
Children), New York
First 
Reproductive 
Health 
Survey (RHS) 
conducted
First Multiple 
Indicator 
Cluster 
Survey (MICS) 
conducted
World Population 
Conference (World 
Population Plan 
of Action/WPPA), 
Bucharest
First World Fertility 
Survey (WFS) 
conducted
International 
Conference on 
Primary Health 
Care (Alma-Ata 
Declaration), 
Alma-Ata
Millennium Summit 
 
(UN Millennium Declaration), New York
United Nations 
Inter-Agency Group 
for Child Mortality 
Estimation (UN 
IGME) formed
World Health Assembly resolution: 
Working towards universal 
coverage of maternal, 
newborn and child 
health interventions
Newborn Indicators  
Technical Working Group convened
PMNCH launched
UN’s Maternal 
Mortality 
Estimation Inter-
Agency Group  
(UN MMEIG) 
formed
Global Strategy 
for Women’s and 
Children’s Health (and 
Every Woman Every 
Child) 
launched
World Health Assembly 
resolution: Newborn 
health  
action plan 
endorsed
Ending Preventable 
Maternal Mortality 
(EPMM) strategy
ENAP Metrics Working 
Group convened 
(expanded in 2015 to 
include EPMM)
Mother and Newborn Information 
for Tracking Outcomes and Results 
(MoNITOR) convened – a technical 
advisory group
Maternal Morbidity 
Working Group 
(MMWG) formed
The 2030 Agenda for Sustainable 
Development, 2016–2030, and 
the Sustainable Development 
Goals (SDGs) adopted
established
Indicator and 
monitoring 
framework for 
the GSWCAH 
(2016–2030)
INDICATOR AND 
MONITORING 
FRAMEWORK FOR THE 
GLOBAL STRATEGY FOR 
WOMEN’S, CHILDREN’S 
AND ADOLESCENTS’ 
HEALTH  
(2016-2030)
Commission on Information and Accountability for 
Women’s and Children’s Health (CoIA)
established
Fourth World 
Conference 
on Women, 
Beijing
Every Newborn Action Plan 
(ENAP) launched
First Demographic 
and Health Survey 
(DHS) conducted
Global Maternal Newborn Health 
Conference, Mexico City
Strategies toward ending
preventable maternal 
mortality (EPMM)
Child Health Epidemiology Reference Group 
(CHERG) established by WHO (now known 
as the Maternal and Child Epidemiology 
Estimation Group [MCEE])
Global Strategy for Women’s, 
Children’s and 
Adolescents’ 
2016–2030, 
launched
UN Millennium Project 
and Millennium 
Campaign  
(2000–2015)
Maternal Health Task 
Force (MHTF) formed
first global 
conference, London
Health (GSWCAH), 
Figure 1 Key global initiatives and events related to maternal and newborn health.
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Table 1 Global goals and summary data
MDG targets for 2015 MDG 5 –
Improve maternal health; MDG 4 –
Reduce child mortality
Percentage gains per target during the MDG era
(from 1990 to 2015) 2015 data in bold
SDG targets for 2030 SDG 3 – Ensure
healthy lives and promote well-being for
all at all ages
Maternal mortality
MDG Target 5.A: Reduce by
three quarters, between
1990 and 2015, the
maternal mortality ratio
(MMR)
5.1 MMR reduced by* SDG Target 3.1:
World: 44% (from 385 to 216 deaths per 100,000
live births)
By 2030, reduce the global MMR to less
than 70 per 100,000 live births
Developing regions: 44% (from 430 to 239)
Developed regions: 48% (from 23 to 12)
5.2 Proportion increased by†
Indicators: World: 28% (from 59% to 75.4%) Indicators:
5.1 MMR per 100,000 live
births;
Developing regions: 28% (from 57% to 73.1%) 3.1.1 MMR;
5.2 Proportion of births
attended by skilled health
personnel (%)
Developed regions: 1990 data not found.
98.7% in 2015
3.1.2 Proportion of births attended by
skilled health personnel
Child mortality
MDG Target 4.A: Reduce by
two-thirds, between 1990
and 2015, the under-five
mortality rate (U5MR)
4.1 U5MR reduced by‡ SDG Target 3.2.1:§ By 2030, end
preventable deaths of children under
5 years of age, with all countries aiming
to reduce under-5 mortality to at least
as low as 25 per 1000 live births
World: 53.3% (from 91 to 43 per 1000 live births)
Developing regions: 54% (from 100 to 47)
Developed regions: 60% (from 15 to 6)
Indicators: 4.2 IMR reduced by‡
4.1 U5MR per 1000 live births; World: 49.2% (from 63 to 32 per 1000 live births)
4.2 Infant mortality rate (IMR)
per 1000 live births
Developing regions: 49.3% (from 69 to 35) Indicator:
Developed regions: 58.3% (from 12 to 5) 3.2.1 U5MR
Neonatal mortality
No MDG target or other global
target was set for neonatal
mortality for 2015
NMR reduced by‡ SDG Target 3.2.2:§ By 2030, end
preventable deaths of newborns, with all
countries aiming to reduce neonatal
mortality to at least as low as 12 per
1000 live births
World: 47% (from 36 to 19 per 1000 live births)
Indicator: Developing regions: 48% (from 40 to 21)
Neonatal mortality rate (NMR)
per 1000 live births
Developed regions: 63% (from 8 to 3) Indicator:
3.2.2 NMR
See also Box 4
Stillbirths
No MDG target or other global
target was set for stillbirths
for 2015
SBR reduced from 2000k to 2015 by¶ No SDG target was set for stillbirths, but
targets were set by the Every Newborn
Action Plan (ENAP; see Box 4]
World: 25.5% (from 24.7 to 18.4)
Indicator: Developed regions: 24.4% (from 4.5 to 3.4) Indicator: SBR
Stillbirth rate (SBR) per 1000
total births
Sub-Saharan Africa (highest of all regions):
19.4% (from 35.6 to 28.7)
As explained in the MDG report ‘Since there is no established convention for the designation of “developed” and “developing” coun-
tries or areas in the United Nations system, this distinction is made for the purposes of statistical analysis only’.
*Data from Trends in maternal mortality, WHO 2015 [20].
†1990 data from The Millennium Development Goals report 2015 [26]; 2015 data from Progress towards the Sustainable Develop-
ment Goals: Report of the Secretary-General, Statistical annex: global and regional data for Sustainable Development Goal indicators (
https://unstats.un.org/sdgs/files/report/2016/secretary-general-sdg-report-2016–Statistical-Annex.pdf).
‡Data from Levels and trends in child mortality: report 2015, UNIGME 2015 [27].
§Target 3.2 has been split in two (3.2.1 and 3.2.2) to separate out the targets for children (under 5 years old) and newborns (as was
also done in the Indicator and monitoring framework for the GSWCAH).
¶Data from Blencowe et al. 2016 [12] by MDG region.
k1990 baseline not available.
© 2019 World Health Organization. Tropical Medicine & International Health Published by John Wiley & Sons Ltd. 1347
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conference, by which time 123 countries were promoting
family planning (up from 59 a decade earlier), recom-
mendations were adopted for the further implementation
of the WPPA [32], with more detailed information and
more specific recommendations. But it was not until the
1994 conference (see ‘Key conferences’ below) that repro-
ductive health and rights were truly put front and centre.
The Alma-Ata Declaration and ‘Health for All’: sights set
on the year 2000
Over forty years ago, in 1978, WHO and UNICEF con-
vened the International Conference on Primary Health
Care, which culminated with the Alma-Ata Declaration.
A major 20th-century milestone in the field of public
health, the Declaration, identified primary health care as
the key to ‘Health for All’. This goal had been articulated
in 1977 at the World Health Assembly (WHA): ‘the main
social target of governments and of WHO should be the
attainment of all the people of the world by the year
2000 of a level of health that will permit them to lead a
socially and economically productive life’ [33]. Crucially,
the Declaration identified MCH care, including family
planning, as components of basic and essential primary
health care [34]. In 1979, the WHA endorsed the Alma-
Ata Declaration and launched the Global Strategy for
Health for All by the Year 2000, which was formally
adopted in 1981 [33].
The Safe Motherhood Conference: the big push to reduce
maternal mortality
While the importance of MCH had received verbal
support at the UN population conferences and in the
Alma-Ata Declaration, only child health interventions
and family planning subsequently received major funding,
from the United Nations Children’s Fund (UNICEF) and
the United Nations Population Fund (UNFPA), respec-
tively. This was part of the ‘selective primary healthcare’
strategy aimed at high coverage of interventions for the
most important diseases in less developed regions, viewed
as the most cost-effective approach to public health until
‘comprehensive primary health care’ could be available to
all [35]. This led Rosenfield and Maine to publish their
seminal 1985 paper declaring maternal mortality a
neglected tragedy and asking ‘Where is the M in MCH?’
[36], cited the estimated 500,000 annual maternal deaths
mentioned by the Director General of WHO during the
WHA in 1979. The authors argued for ‘a dramatic shift
in priorities’ and ‘major investment in a system of com-
prehensive maternity care’, calling upon the World Bank
to prioritise maternal mortality and take the lead in
building and funding a preventive health programme
[36]. Also in 1985, during a conference marking the end
of the UN Decade for Women, a WHO speaker
announced the same estimate of half a million annual
maternal deaths [37]. In response to increasing concern
and demand for data, WHO published 1983 data in
1986 [38] and began monitoring trends, continually
improving the modelling and estimation methods, and
publishing reports every few years (see Table 2).
The culmination of this gathering momentum – when
maternal mortality achieved high-priority status – was
the Safe Motherhood Conference in 1987 in Nairobi,
Kenya, co-sponsored by the World Bank, WHO and
UNFPA. At the event, WHO’s Director General
acknowledged that maternal mortality had indeed been a
neglected tragedy, ‘because those who suffer it are
neglected people, with the least power and influence over
how national resources shall be spent’ [48]. The Safe
Motherhood Initiative (SMI) was launched, including a
plan for halving maternal mortality by 2000, and calling
for cost-effective health services delivered through a
three-tiered system: village/community level; hospital/dis-
trict level; and an ‘alarm and transport’ system to transfer
women to appropriate facilities [49]. Reportedly, many
conference participants ‘noted that reliable data on
maternal mortality and morbidity in developing countries
are either unavailable or incomplete and agreed that there
is an urgent need to develop appropriate record-keeping
systems at all levels’, to help countries monitor and
improve women’s health [49]. Appendix 1 provides sum-
mary information on population-based surveys reporting
on maternal, newborn and child health (MNCH) since
the 1970s, and Appendix 2 briefly describes the particular
challenges and methods of measuring and monitoring
maternal mortality.
After the conference, the Safe Motherhood Inter-
Agency Group (IAG) was established by the World Bank,
WHO, UNFPA, UNICEF, the United Nations Develop-
ment Programme (UNDP), International Planned Parent-
hood Federation (IPPF) and the Population Council
[37,50] as a forum for continued collaboration to achieve
the SMI goals. In 2004, the IAG evolved to become the
Partnership for Safe Motherhood and Newborn Health.
In the spirit of the Alma-Ata Declaration, the main
interventions prioritised under the SMI were community-
based preventive-care interventions, including screening
pregnant women for risks of complications and training
traditional birth attendants to improve community-level
delivery care. Both of these approaches were dropped
after it was acknowledged at the 10th anniversary confer-
ence in 1997 that they had not been effective at reducing
maternal mortality; the new messages were ‘every
1348 © 2019 World Health Organization. Tropical Medicine & International Health Published by John Wiley & Sons Ltd.
Tropical Medicine and International Health volume 24 no 12 pp 1342–1368 december 2019
A.-B. Moller et al. Monitoring maternal and newborn health
Table 2 Global estimates of MMR and lifetime risk of maternal death produced by WHO and partner agencies, published from 1985
to 2019
Tabulations of available information by the World Health Organization (WHO)
Publication date and title Description and key reported estimates
1985: Maternal mortality rates: a tabulation of
available information (unpublished)
This report was compiled and informally disseminated (but not published) by WHO,
in response to many requests for information.
1986: Maternal mortality rates: a tabulation of
available information, second edition [38]
Estimates for 1983:
Maternal deaths in 1983/annual: 500,000 (99% of these in developing countries,
where 86% of births take place).
MMR:
World: 390
Developing countries: 450
Developed countries: 30
Region with highest MMR: Western Africa, 700
1991: Maternal mortality ratios and rates: a
tabulation of available information, third
edition [39]*
Estimates for 1988:
Maternal deaths in 1988: 509,000
MMR:
World: 370 (lifetime risk of maternal death [LR]: 1 in 73)
Developing countries: 420 (LR: 1 in 57)
Developed countries: 26 (LR: 1 in 1825)
Region with highest MMR: Western Africa, 760 (LR 1 in 18)
WHO and UNICEF collaboration to develop revised 1990 estimates using a new approach
1996: Revised 1990 estimates of maternal
mortality: a new approach by WHO and
UNICEF [40]†
Estimates for 1990:
Maternal deaths in 1990: 585,000
MMR:
World: 430 (LR: 1 in 60)
Less developed regions: 480 (LR: 1 in 48)
More developed regions: 27 (LR: 1 in 1800)
Region with highest MMR: Eastern Africa, 1060 (LR: 1 in 12)
Series of estimates of maternal mortality developed by WHO and UN partners
2001: Maternal mortality in 1995: estimates
developed by WHO, UNICEF, UNFPA [41]
Estimates for 1995:
Maternal deaths in 1995: 515,000
MMR:
World: 400 (LR: 1 in 75)
More developed countries: 21 (LR: 1 in 2500)
Less developed countries: 440 (LR: 1 in 60)
Least developed countries: 1000 (LR: 1 in 16)
Region with the highest MMR: Eastern Africa, 1300 (LR: 1 in 11)
2004: Maternal mortality in 2000: estimates
developed by WHO, UNICEF, UNFPA [42]
Estimates for 2000:
Maternal deaths in 2000: 529,000
MMR:
World: 400 (LR: 1 in 74)
Developing regions: 440 (LR: 1 in 61)
Developed regions: 20 (LR: 1 in 2800)
Region with the highest MMR: Sub-Saharan Africa, 920 (LR: 1 in 16)
2007: Maternal mortality in 2005: estimates
developed by WHO, UNICEF, UNFPA and
The World Bank [43]
Estimates for 2005:
Maternal deaths in 2005: 536,000 (99% in developing countries)
MMR:
World: 400 (LR: 1 in 92)
Developing regions: 450 (LR: 1 in 75)
Developed regions: 9 (LR: 1 in 7300)
Region with highest MMR: Sub-Saharan Africa, 900 (LR: 1 in 22)
(Continues)
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Table 2 (Continued)
Tabulations of available information by the World Health Organization (WHO)
Series of estimates and trends of maternal mortality developed by the UN’s Maternal Mortality Estimation Inter-Agency Group (UN
MMEIG) – WHO, UNICEF, UNFPA, World Bank Group and UNPD*
2010: Trends in maternal mortality: 1990 to
2008: estimates developed by WHO,
UNICEF, UNFPA and The World Bank [44]
Estimates for 2008, and revised estimates for 1990, 1995, 2000, 2005
Maternal deaths in 2008: 358,000
MMR in 2008:
World: 260 (LR: 1 in 140)
Developing regions: 290 (LR: 1 in 120)
Developed regions: 14 (LR: 1 in 4300)
This and later reports use UN MDG regions Region with the highest MMR: Sub-Saharan Africa, 640 (LR: 1 in 31)
2012: Trends in maternal mortality: 1990 to
2010: WHO, UNICEF, UNFPA and The
World Bank estimates [45]
Estimates for 2010, and revised estimates for 1990, 1995, 2000, 2005
Maternal deaths in 2010: 287,000
MMR in 2010:
World: 210 (LR: 1 in 180)
Developing regions: 240 (LR: 1 in 150)
Developed regions: 16 (LR: 1 in 3800)
Region with the highest MMR: Sub-Saharan Africa, 500 (LR: 1 in 39)
2014: Trends in maternal mortality: 1990 to
2013: estimates by WHO, UNICEF, UNFPA,
The World Bank and the United Nations
Population Division [46]
Estimates for 2013, and revised estimates for 1990, 1995, 2000, 2005, 2010
Maternal deaths in 2013: 289,000
MMR in 2013:
World: 210 (LR: 1 in 190)
Developing regions: 230 (LR: 1 in 160)
Developed regions: 16 (LR: 1 in 3700)
Region with the highest MMR: Sub-Saharan Africa, 510 (LR: 1 in 38)
2015: Trends in maternal mortality: 1990 to
2015: estimates by WHO, UNICEF, UNFPA,
World Bank Group and the United Nations
Population Division [[20]]
Estimates for 2015, and revised estimates for 1990, 1995, 2000, 2005, 2010 (see
Table 3)
Maternal deaths in 2015: 303,000
MMR in 2015:‡
World: 216 (LR: 1 in 180)
Developing regions: 239 (LR: 1 in 150)
Developed regions: 12 (LR: 1 in 4900)
Region with the highest MMR: Sub-Saharan Africa, 546 (LR: 1 in 36)
2019: Trends in maternal mortality: 2000 to
2017: estimates by WHO, UNICEF, UNFPA,
World Bank Group and the United Nations
Population Division [1]
Estimates for 2017, and revised estimates for 2000, 2005, 2010, 2015
Maternal deaths in 2017: 295,000
MMR in 2017:
World: 211 (LR: 1 in 190)
Less developed regions: 232 (LR: 1 in 160)
More developed regions: 12 (LR: 1 in 5200)
Data from each report cannot be meaningfully compared to data from previous reports/years due to subsequent advances in modelling/
estimation methods for each publication. The UN MMEIG was formed in 2010. The estimates presented in each Trends in maternal
mortality report listed above supersede all previously published estimates for years that fall within the same time period due to modifi-
cations in methodology and data availability. Therefore, differences between newer and previous estimates should not be interpreted as
representing time trends; trends should only be interpreted as presented within each separate publication for the years covered [1].
*In addition to the reports of estimates and trends in maternal mortality, WHO also published Maternal mortality: a global factbook
in 1991, presenting 1983 MMR estimates as well as 1985 estimates for coverage of maternity care (per cent of births with a trained
attendant), country profiles compiling all available demographic and maternal health information, and detailed information about mea-
suring maternal mortality [47].
†These revised 1990 estimates were required because the model used to calculate previous 1990 estimates could not support accurate
country-level estimates but just regional and global estimates. The earlier 1990 estimates were inadvertently published in the 1992
Human Development Report but were never used.
‡Unfortunately, these estimates were not available before the 2015 MDG report was published in the same year [26], so that report
used the 1990 baseline and 2013 MMR estimates from the previous (2014) UN MMEIG publication.
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pregnancy faces risks’ and ‘ensure skilled attendance at
delivery’. Focus on safe motherhood became diffused in
efforts to address the plethora of contributing factors fac-
ing girls and women, such as early marriage, lack of
access to education and contraception, and poor nutri-
tional, socio-economic and legal status [37]. Certainly,
the SMI goal of halving maternal mortality by 2000 was
not reached: global MMR fell 11% from 385 to 341
maternal deaths per 100,000 live births between 1990
and 2000 (see Table 3) [20]. Nevertheless, the conference
kick-started a process of raising global awareness,
developing and implementing effective interventions, and
improving measurement approaches.
Key conferences and goals set in the 1990s: paving the
way to the MDGs
Three major global conferences in the 1990s built on the
momentum and concern surrounding maternal mortality
after the Safe Motherhood Conference. They also reiter-
ated and/or expanded upon the SMI’s main goal of halv-
ing maternal mortality by 2000. First was the 1990
World Summit for Children, in New York City. The first
two major goals of the ‘World Declaration on the Sur-
vival, Protection and Development of Children’ were to
reduce the infant mortality rate (IMR) and U5MR by
one-third, and to reduce the MMR by half by 2000 [52].
Next, in 1994, the UN’s third and final official world
conference on population was held in Cairo, the Interna-
tional Conference on Population and Development
(ICPD). The ICPD’s widely lauded Programme of Action
(PoA) – as Ban Ki-moon later stated – ‘put people’s
rights at the heart of development’ and ‘affirmed sexual
and reproductive health as a fundamental human right’
[11]. The World Summit for Children’s targets for
reducing IMR, U5MR and MMR by 2000 were
adopted, and targets for 2015 were added. Targets for
providing universal access to reproductive health (RH)
services were also set. The PoA was adopted by 179
countries, and its MCH and RH action points and tar-
gets directly laid the groundwork for MDGs 4 and 5 set
in 2000 (see MDG targets in Table 1 and ICPD objec-
tives/targets in Box 3). No targets were set for neonatal
mortality, morbidity or stillbirths (the same was true of
the World Summit for Children), but the connection
between child survival and maternal RH was noted (and
a definition of RH was presented; see Box 1). The wide
gap between maternal mortality in higher- and lower-in-
come regions was a critical part of the ‘basis for action’,
and emphasis was also placed on ‘adequate evaluation
and monitoring’ to assess progress and enhance pro-
gramme effectiveness [11].
Just a year later, the Declaration issued by the 1995
Fourth World Conference on Women, in Beijing,
included the following point: ‘The explicit recognition
and reaffirmation of the right of all women to control all
aspects of their health, in particular their own fertility, is
basic to their empowerment’ [53]. An agreed action point
was to ‘reduce ill health and maternal morbidity’. The
Beijing Declaration restated the 2000 and 2015 targets
for reducing IMR, U5MR and MMR set at the ICPD (see
Box 3) [53], adding further weight to these goals.
Table 3 Trends in United Nations estimates of maternal mortality ratios (MMR), neonatal mortality rates (NMR) and stillbirth rates
(SBR), during the MDG era: 1990–2015
Region 1990 1995 2000 2005 2010 2015 % change 1990–2015
MMR*
World 385 369 341 288 246 216 44
Developed regions 23 22 17 15 13 12 48
Developing regions 430 409 377 319 273 239 44
NMR
World† 37 34 31 26 22 19 49
Developed regions‡ 8 NA NA NA NA 3 58
Developing regions‡ 40 NA NA NA NA 21 47
SBR§ % change 2000–2015
World NA NA 24.7 NA NA 18.4 25.5
Developed regions NA NA 4.5 NA NA 3.4 24.4
Sub-Saharan Africa NA NA 35.6 NA NA 28.7 19.4
*WHO 2015 [20] by UN MDG region.
†UNIGME 2018 [51] by SDG region.
‡UNIGME 2015 [27] by MDG region (only available for 1990 and 2015).
§Blencowe.
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Box 3 ICPD objectives and targets for improvement of maternal and child health, from the PoA section on ‘Health,
morbidity and mortality’
Child survival and health
Objectives:
(a) To promote child health and survival and to reduce disparities between and within developed and developing
countries as quickly as possible, with particular attention to eliminating the pattern of excess and preventable mor-
tality among girl infants and children;
(b) To improve the health and nutritional status of infants and children. (c) To promote breastfeeding as a child
survival strategy.
Relevant action points/targets:
• ‘Countries should strive to reduce their infant and under-five mortality rates by one-third, or to 50 and 70 per
1,000 live births, respectively, whichever is less, by the year 2000, with appropriate adaptation to the particular
situation of each country’.
• ‘By 2015, all countries should aim to achieve an infant mortality rate below 35 per 1,000 live births and an
under-five mortality rate below 45 per 1,000’.
Women’s health and safe motherhood
Objectives:
(a) To promote women’s health and safe motherhood; to achieve a rapid and substantial reduction in maternal
morbidity and mortality and reduce the differences observed between developing and developed countries and within
countries. On the basis of a commitment to women’s health and well-being, to reduce greatly the number of deaths
and morbidity from unsafe abortion;
(b) To improve the health and nutritional status of women, especially of pregnant and nursing women.
Relevant action points/targets:
• ‘Countries should strive to effect significant reductions in maternal mortality by the year 2015: a reduction in
maternal mortality by one half of the 1990 levels by the year 2000 and a further one half by 2015’.
• ‘All births should be assisted by trained persons, preferably nurses and midwives, but at least trained birth atten-
dants’.
Reproductive rights and reproductive health
Objectives:
(a) To ensure that comprehensive and factual information and a full range of reproductive healthcare services,
including family planning, are accessible, affordable, acceptable and convenient to all users;
(b) To enable and support responsible voluntary decisions about childbearing and methods of family planning of
their choice, as well as other methods of their choice for regulation of fertility which are not against the law and to
have the information, education and means to do so;
(c) To meet changing reproductive health needs over the life cycle and to do so in ways sensitive to the diversity
of circumstances of local communities.
Relevant action points/targets:
• ‘All countries should strive to make accessible through the primary healthcare system, reproductive health to all
individuals of appropriate ages as soon as possible and no later than the year 2015’.
Source: United Nations 2014 [11]
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Improved monitoring of obstetric services to reduce
maternal mortality
In 1997, in direct response to the stated challenge to halve
MMR by 2000 and reduce it by three quarters by 2015 –
targets which had already been mentioned and endorsed in
multiple international initiatives and publications – UNI-
CEF, WHO and UNFPA issuedGuidelines for monitoring
the availability and use of obstetric services. This publica-
tion aimed to support countries to regularly monitor pro-
gress by assessing the quality and coverage of interventions
aimed at improving emergency obstetric services to reduce
maternal mortality; it presented revised process indicators,
and guidance and tools for data collection and analysis
[54]. In 2009, an updated handbook was published [55] a
collaborative effort by WHO, UNFPA, UNICEF and
Averting Maternal Death and Disability (AMDD).
The MDG era: setting targets for 2015 and tracking
progress
In September 2000, world leaders came together at the
UN in New York for the Millennium Summit to adopt
the UN Millennium Declaration, committing their
nations to a new global partnership to eradicate extreme
poverty, and setting out a series of goals to be achieved
by 2015, which soon came to be known as the MDGs.
The Declaration, signed by 189 countries, included the
resolution ‘to have reduced maternal mortality by three
quarters, and under-five child mortality by two-thirds, of
their current rates’ by 2015 [56], formalising similar tar-
gets set at the ICPD.
When the wording of all eight MDGs was later fina-
lised, with associated targets and indicators for each,
MDG 5 – ‘Improve maternal health’ – included target
5.A: ‘Reduce by three quarters, between 1990 and 2015,
the maternal mortality ratio (MMR)’. There was no tar-
get addressing maternal morbidity, but target 5.B –
‘Achieve, by 2015, universal access to reproductive
health’ – was officially added to the MDGs in 2006 after
the importance of this goal – originally set at the ICPD –
was reaffirmed by leaders at the 2005 UN World Summit
[57]. MDG 4 was ‘Reduce child mortality’, and target
4.A was ‘Reduce by two-thirds, between 1990 and 2015,
the under-five mortality rate’ (see Table 1). No targets or
Box 4 Every Newborn Action Plan (ENAP) and Ending Preventable Maternal Mortality (EPMM) goals and targets
ENAP goals
1. By 2035, all countries will reach the target of 10 or less newborn deaths per 1000 live births and continue to
reduce death and disability, ensuring that no newborn is left behind. Achievement of this target will result in an
average global neonatal mortality rate (NMR) of 7 deaths per 1000 live births.
- By 2030, all countries will reach 12 of less newborn deaths per 1000 live births resulting in an average global
NMR of 9 deaths per 1000 live births.
2. By 2035, all countries will reach the target of 10 or less stillbirths per 1000 total births and continue to close
equity gaps. Achieving this goal will result in an average global stillbirth rate (SBR) of 8 per 1000 total births.
- By 2030, all countries will reach 12 or less stillbirths per 1000 total births, resulting in an average global SBR of
9 deaths per 1000 total births.
These goals are supported by a set of six guiding principles and five strategic objectives, as well as specific, evi-
dence-based interim coverage targets for 2020 and 2025, and global and national milestones to be reached by 2020.
Source: WHO 2014 [24].
EPMM targets
• Global target to increase equity in maternal mortality between countries: By 2030, all countries should reduce
maternal mortality ratio (MMR) by at least two-thirds of their 2010 baseline level. The average global target is
an MMR of less than 70 maternal deaths per 100 000 live births by 2030.
• Supplementary national target: By 2030, no country should have an MMR greater than 140, a number twice the
global target.
Country targets for 2030 were also set, depending on baseline levels of MMR, to increase equity in maternal mor-
tality, since the global target may not be applicable to individual countries.
Source: WHO 2015 [90].
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indicators were specified for neonatal mortality or mor-
bidity, or for stillbirths.
In the decade leading up to the MDG era – when
health and development goals to be measured against the
1990 level were already gaining traction – and in the
decade after the launch of the MDGs – when 1990 had
been fixed as the official baseline – there was a major
drive to develop accurate global, regional and national
estimates for the year 1990. With these efforts to estab-
lish the baseline data and monitor subsequent progress,
the MDG era prompted improvements in data collection
and analysis methods for maternal and child mortality.
The MMR estimates proved especially challenging and
have been revised frequently; the final UN data for the
MDG era were published in 2015 [20], and new esti-
mates for 2000–2017 have been published in 2019 [1].
Efforts to improve the measurement of MMR were inten-
sified in the last five years of the MDG era with the for-
mation in 2010 of the UN’s Maternal Mortality
Estimation Inter-Agency Group (UN MMEIG) – compris-
ing WHO, UNICEF, UNFPA, World Bank Group and
UNPD – to harmonise various UN estimates and improve
estimation and modelling methods [58] (see the final sec-
tion of Table 2, and Appendix 2).
In parallel to estimation work of the UN MMEIG, the
Institute for Health Metrics and Evaluation (IHME) at
the University of Washington in Seattle, USA, has also
published a number of reports of global, regional and
national estimates of maternal mortality (number of
deaths and MMRs) since 2010. Both groups use model-
based estimates, but use different modelling approaches
including the model specification, selection of covariates
and approach to addressing HIV-related deaths. In addi-
tion, the UN MMEIG engages countries in an official
WHO country consultation process when the preliminary
estimates have been derived, to discuss methods and data
inputs before the global, regional and national data are
finalised and published. More details about the estimates
generated by the different entities can be found in a 2011
publication by AbouZahr [59].
The ‘Countdown to 2015’ collaboration of UN agen-
cies, implementing partners and academics was estab-
lished in 2003 to support monitoring of the coverage of
interventions needed to reduce maternal and child mor-
tality and to promote accountability from governments
and partners working to provide equitable coverage of
these interventions [60,61]. Progress reports for stake-
holders were issued every two to three years. While origi-
nally focusing on newborn and child survival [62],
subsequent reports encompassed the MNCH continuum
of care, expanding the selection criteria used for the pri-
ority countries, such that the final 2015 report covered
75 priority countries, which accounted for more than
95% of all maternal, newborn and child deaths [63]. The
Countdown ‘country profiles’ were hailed as a key
achievement for tracking country-level progress towards
the MDGs.
The MDG era also sparked other key global initiatives
such as Women Deliver, an organisation focused on gen-
der equality and girls’ and women’s health and rights
(the first Women Deliver conference was held in London
in 2007, marking the 20th anniversary of the Safe
Motherhood Conference), and the 2008 launch of the
Maternal Health Task Force (MHTF) at the Harvard
Chan School of Public Health.
Neonatal mortality: slowly gaining prominence in the
global health agenda
Although none of the major conferences in the 1990s
included a focus on neonatal mortality, morbidity or still-
births, there were some efforts to monitor these out-
comes. In 1996, WHO published available data on
perinatal mortality [64], a decade after first publishing
available MMR data [38]. The report estimated almost
4.3 million foetal deaths and more than 5 million neona-
tal deaths in 1995, recommending that ‘To reduce infant
deaths substantially, the focus will have to be on reduc-
ing neonatal deaths, particularly in the early neonatal
period when more than four out of 10 infant deaths and
most neonatal deaths occur’ [64]. Despite this timely
publication and recommendation, no targets for neonatal
mortality or stillbirths were included in the MDGs.
Key publications and events in 2005 raised the profile
of the burden of neonatal mortality. In March, The Lan-
cet Neonatal Survival Series drew attention to a ‘crucial
omission in global health research and policy’ [65]. The
series culminated in a call to focus on improving neonatal
survival to meet MDG target 4.A on U5MR, and to add
a target to reduce neonatal mortality [66]. Weeks later,
WHO’s World Health Report 2005 – Make every mother
and child count reported ‘patchy progress and widening
gaps’ and included a chapter titled ‘Newborns: no longer
going unnoticed’ [67]. In May 2005, a WHA resolution
was issued for universal coverage of MNCH interven-
tions, putting maternal, newborn and child health and
survival together as the top priority for ministers of
health [62]. It urged Member States ‘to establish or sus-
tain national and international targets, and to establish
monitoring mechanisms for measuring progress towards
the achievement of agreed goals’ [68]. By this time, the
familiar abbreviation ‘MCH’ had evolved into ‘MNCH’
– placing newborns firmly into the mix. Groups focusing
on maternal and/or child health began to embrace issues
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of newborn survival. In September 2005, the Partnership
for Maternal, Newborn and Child Health (PMNCH) was
launched, bringing together three existing partnerships –
the Partnership for Safe Motherhood and Newborn
Health, the Healthy Newborn Partnership and the Child
Survival Partnership – to support the achievement of
MDGs 4 and 5 [69]. PMNCH emphasises the importance
of providing services along the full continuum of care for
women and children; it now includes more than 1000
partners in 77 countries [69].
Soon after this surge of activity in 2005 relating to
newborn survival, in 2006, WHO published data on
global, regional and national neonatal and perinatal
mortality and stillbirth rates for 2000 [70], and then
published data for 2004 a year later, ‘in response to a
surge in national community studies and acknowledging
improved reporting of vital registration data’ [71]. The
2004 data indicated a global NMR of 28 per 1000 live
births, with shocking disparity between higher- and low-
income countries: 4 vs 41.
The UN Inter-Agency Group for Child Mortality Esti-
mation (UN IGME), led by UNICEF and WHO, was
formed in 2004 to improve, share and harmonise data on
child mortality [72]. Since 2010, the group has published
annual reports on ‘Levels and trends in child mortality’,
using data from their collaborative research initiatives
and national household surveys, such as the Demographic
and Health Surveys (DHS) and the Multiple Indicator
Cluster Surveys (MICS) (see Appendix 1). The group
tabulated NMRs for the first time in 2011, noting that
‘over the last two decades almost all regions have seen
slower declines in neonatal mortality than in under-five
mortality’ [73]. Their 2018 report presents the estimates
for 2017, and five-yearly estimates since 1990 [51] and
the latest neonatal mortality data for 1990–2018 have
been released in September 2019 [2] (see global data in
Table 3).
To focus attention on newborn health, in 2008 Saving
Newborn Lives (SNL; an initiative of Save the Children)
convened the Newborn Indicators Technical Working
Group (TWG) with representatives from SNL, UNICEF,
USAID, DHS and other implementing partners. The
TWG was established to assess and develop standardised
indicators to monitor and evaluate newborn health –
indicators that can be tracked via population-based sur-
veys (e.g. DHS and MICS), independent studies and rou-
tine health information systems [74].
Between 2010 and 2015, there was a proliferation of
global initiatives with an explicit focus on newborns,
beginning with the Muskoka Initiative for MNCH, a
five-year major funding commitment agreed at a G-8
Summit in 2010 [75]. In 2012, the Child Survival Call to
Action was convened jointly by UNICEF and the govern-
ments of Ethiopia, India and the USA, leading to the
launch of A Promise Renewed – ‘a global effort to accel-
erate action on maternal, newborn and child survival’
[76]. More than 178 governments and 600 civil society
and private sector organisations pledged support [77].
Then in April 2013, the first Global Newborn Health
Conference was held in Johannesburg, with participants
from more than 50 countries [78]. The conference
included preliminary consultation on the development of
a global newborn action plan and a common monitoring
framework. This kicked off a series of further consulta-
tions [79], culminating in the launch of the Every New-
born Action Plan (ENAP) in 2014 [24] (ENAP is
discussed below). Also in 2014, The Lancet published the
Every Newborn Series, including data and trends on
neonatal mortality and proposing national and global tar-
gets; the authors emphasised that ‘To count deaths is cru-
cial to change them’ [80]. In 2015, the ENAP target for
reduction of NMR by 2030 was included in the SDGs
(see Table 1) and in the Global Strategy for Women’s,
Children’s and Adolescents’ Health [81] (see section on
The Global Strategy).
But why did prioritisation of newborn survival lag so
far behind that of maternal survival, despite the much
larger number of annual neonatal deaths, and the fact
that both groups face the highest risks during the perina-
tal period, when women and babies could both be
reached with joined-up interventions? According to the
conclusions of a 2016 study on this subject, which exam-
ined the emergence and growth of political priority for
these issues, maternal survival was strongly positioned as
a social justice issue in the 1980s, drawing attention and
resources since then, while newborn survival came under
the umbrella of ‘maternal and child survival’ but was not
fully adopted by either the ‘maternal’ or ‘child’ camp.
Smith and Shiffman concluded that ‘network expansion
and alignment with child survival norms have improved
the issue’s status in the past few years’ [82].
Stillbirths: bringing them into the fold
We have seen that there was substantial momentum for
better monitoring and faster reduction of neonatal mor-
tality from around 2005 to 2015, when a target for
reduction made it into the SDGs. But it took longer for
stillbirths to be addressed seriously and no SDG target
was set.
In 2006, both WHO [70] and Stanton et al. [83] had
produced very similar estimates of stillbirth rates (SBR)
for 2000, while acknowledging the lack of reliable data
in many countries, and the next year, WHO released
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updated estimates for 2004 [71]. A few years later, in
2009, six new reviews on reducing stillbirths, with a
focus on LMICs, were published in a supplement of
BMC Pregnancy and Childbirth. The issue highlighted
that most stillbirths in LMICs are late pre-term, term and
intrapartum, which are relatively easy to prevent [84].
Lawn et al. reviewed the global epidemiology and causes
of stillbirths as well as the availability and quality of
data, while acknowledging that the relative ‘invisibility’
of stillbirths on the global agenda was due to ‘a lack of
data and a lack of consensus on priority interventions,
but also to social taboos that reduce the visibility of still-
births and the associated family mourning’ [85]. In 2011,
The Lancet Stillbirths Series examined the data and avail-
able interventions, including an analysis by Cousens et al.
presenting SBR estimates for 2009 and trends since 1995.
The authors noted the ‘dearth of reliable data in regions
where most stillbirths occur’ and that SBR was declining
more slowly than MMR and U5MR [86]. Another article
in the series called for the inclusion of stillbirth in rele-
vant international health reports and initiatives, and for
clear targets [87].
SBRs were included for the first time in the ‘Count-
down to 2015’ country profiles in 2010, based on
improved availability of data and evidence of the close
links with maternal and newborn health [63]. In 2014,
in anticipation of the setting of new global goals, the
Every Newborn Action Plan (ENAP) proposed targets
for reducing NMR and SBR (see Box 4, and section
below on ENAP) [24], but despite this and other efforts
to bring stillbirths more firmly onto the global agenda at
that time [88], no target for reducing stillbirths was
included in the SDGs in 2015. Nevertheless, the 2016
Indicator and monitoring framework for the Global
Strategy for Women’s, Children’s and Adolescents’
Health (2016–2030) (see below) included SBR as an
additional indicator linked to SDG target 3.2.2 on
neonatal mortality, and selected it as one of 16 key indi-
cators, along with MMR, U5MR and NMR [15]. In
2016, The Lancet Ending Preventable Stillbirths Series
provided new data and reviewed progress [3,89], and a
systematic analysis of national, regional and global SBR
estimates from 2000 to 2015 was published in The Lan-
cet Global Health [12]. All of this has put greater focus
on stillbirths at this crucial time when more action is
clearly needed.
The Global Strategy: final push on MDGs 4 and 5
The UN Secretary-General’s Global Strategy for
Women’s and Children’s Health was launched at the
2010 UN Summit on the MDGs, to hasten progress
towards MDGs 4 and 5. Key areas for action included
support for country-led plans, and ‘improved monitoring
and evaluation to ensure the accountability of all actors
for results’ [91]. Every Woman Every Child (EWEC) was
launched at the same time – a global movement to enact
the Global Strategy’s roadmap, by mobilising and intensi-
fying national and international action and resources
[92].
After the launch, the UN Secretary-General called on
WHO to ensure ‘the most effective international institu-
tional arrangements for ensuring global reporting, over-
sight and accountability’. In response, the Commission
on Information and Accountability for Women’s and
Children’s Health (CoIA) was established. Its report,
published in 2011, proposed an accountability frame-
work for women’s and children’s health which ‘covers
national and global levels and comprises three intercon-
nected processes – monitor, review and act’ [93]. MMR
and U5MR topped the list of indicators selected for
monitoring the status of women’s and children’s health,
along with stunting in children under 5, and eight cover-
age indicators. The first three of the 10 CoIA recommen-
dations concerned ‘better information for better results’,
relating to improved vital events registration, use of
common indicators, and innovative use of information
and communications technologies in national health sys-
tems.
CoIA’s final recommendation was to establish an inde-
pendent Expert Review Group (iERG) on global report-
ing to operate until 2015 [93]. In its final report, the
iERG concluded that between 2010 and 2015, while the
intention had been to save 16 million lives by achieving
MDGs 4 and 5, in fact just 2.4 million lives were saved
[94]. The next challenges were identified as follows: ‘im-
proving the quality of information available for delivering
accountability, obtaining political commitment, ensuring
regular reporting and strengthening civil society engage-
ment’ [94].
At the end of the MDG era, the Global Strategy was
updated to align with the priorities and timeline (2016–
2030) of the SDGs, and adolescents were added to the
focus. The revised objectives are ‘survive, thrive and
transform’; in other words, ‘to end preventable mortality
and enable women, children and adolescents to enjoy
good health while playing a full role in contributing to
transformative change and sustainable development [81].
The indicator and monitoring framework for the Global
Strategy, published in 2016, is structured around the rele-
vant SDG 3 targets and their 34 indicators, but with 26
‘additional indicators’ (including SBR) drawn from exist-
ing global initiatives [15], such as from ENAP and
EPMM (see below).
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The Every Newborn Action Plan (ENAP) and Ending
Preventable Maternal Mortality (EPMM): convergent
initiatives to guide the SDG agenda on MNCH
ENAP – to end preventable stillbirths and newborn
deaths
In May 2014, the WHA endorsed a resolution for a
‘newborn health action plan’ [95], and WHO subse-
quently launched ENAP, presenting actions and targets
for saving the lives of nearly 3 million babies and women
every year [24]. ENAP acknowledged that newborn
deaths and stillbirths had so far received inadequate
attention and investment, and called for improved ‘access
to, and quality of, health care for women and newborns
within the continuum of care’, building upon the Global
Strategy and EWEC. ENAP set goals for NMR and SBR
reductions by 2030 and 2035 (see Box 4) [24], but while
the NMR target was adopted as an SDG target, the SBR
target was not. One of the five ENAP strategic objectives
is ‘Count every newborn through measurement, pro-
gramme-tracking and accountability’ [24], underlining
‘the urgent need for improved national data’ [96]. The
ENAP Metrics Working Group was formed in September
2014, co-chaired by WHO and the London School of
Hygiene & Tropical Medicine, to work with countries
and partners to meet the ENAP milestones and widely
disseminate tools and learning [97]. The ENAP Measure-
ment Improvement Roadmap was developed in 2015 to
improve data collection by 2020. It outlined tools to be
developed and ‘actions to test, validate and institution-
alise proposed coverage indicators’, working with existing
stakeholders to strengthen health information and civil
registration and vital statistics (CRVS) systems [98]. ‘Ser-
vice readiness for the small and sick newborn’ has been
identified as a major measurement gap, and there is ongo-
ing work to address this and improve the quality of care
for these newborns [96].
EPMM – targets and strategies
Similar to the ENAP initiative and also in anticipation of
the launch of the SDGs, WHO facilitated the development
of a strategy paper on EPMM in 2015 [90], in collabora-
tion with UNICEF, UNFPA, USAID and other partners.
The EPMM strategy focuses on maternal mortality but
encourages linkages with ENAP to address the MNCH
continuum of care [90]. One of the cross-cutting actions
called for is to ‘improve metrics, measurement systems and
data quality’ to ensure that all maternal and newborn
deaths are counted, through effective national surveillance
and CRVS systems in every country [90]. As tools for this,
the EPMM strategy points to standard definitions for
causes of death found in the International Classification of
Diseases (ICD), together with WHO guidance on their
application [4], as well as use of Maternal Death Surveil-
lance and Response (MDSR) systems, perinatal death
surveillance, confidential enquiries and other data sources
(see Appendix 2). EPMM proposed new ‘ambitious yet fea-
sible’ targets for 2030 (see Box 4) – the MMR target was
adopted as SDG target 3.1 – and a monitoring framework
was developed [99,100].
Convergence and merging of ENAP and EPMM and
MNCH initiatives
The ENAP Metrics Working Group and the EPMM
Working Group merged in 2015 to harmonise their tar-
gets, indicators and other considerations, in line with the
Global Strategy and EWEC (see previous section), creat-
ing the joint indicator and monitoring framework for the
Global Strategy [15]. In addition, in 2015 WHO
launched MoNITOR (Maternal and Newborn Informa-
tion Tracking for Outcomes and Results) – a technical
advisory group of 14 independent global experts – ‘to
ensure harmonised guidance, messages, and tools so that
countries can collect useful data to track progress
towards achieving the Sustainable Development
Goals’[101]. MoNITOR is in the process of publishing
recommendations on priority indicators for monitoring
maternal and newborn health (MNH) [102]. Also in
2015, the Global Maternal Newborn Health Conference
was held in Mexico City, bringing together partners
working on the implementation and monitoring of
ENAP, EPMM and other MNH initiatives, ‘to share new
evidence, identify opportunities and gaps, build under-
standing across disciplinary boundaries, and discuss the
way forward to improve maternal and newborn health
around the globe’ [103].
Monitoring maternal and neonatal morbidity: the
missing pieces
This paper has so far examined the challenging process
of getting maternal mortality, neonatal mortality and
finally stillbirths onto the global health and development
agenda. Similar efforts to raise the profile of maternal
and neonatal morbidity with improved monitoring
remain at a nascent stage. There are no internationally
agreed and tracked indicators(potential candidates are
listed in Box 2), but research is ongoing. For some per-
spective on these efforts, we need to step back, to around
the turn of the millennium.
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Maternal morbidity
In 2004, WHO conducted a systematic review of the
incidence and prevalence of maternal mortality and
morbidity [104]. Although thousands of articles were
retrieved, the reporting quality was generally low and
methodological challenges hindered the review process.
Another systematic review that year by some of the same
authors investigated the prevalence of severe acute maternal
morbidity (SAMM, also termed ‘near miss’), but the need
for uniform criteria presented a major challenge [105].
Faced with these difficulties, WHO established a work-
ing group to develop a standard definition of and uni-
form criteria for ‘maternal near miss’ (MNM). In 2009,
the group published their definition of MNM (see Box 1)
and proposed case-identification criteria and MNM-based
indicators for monitoring quality of obstetric care [6].
Given the interest in MNM as an adjunct to maternal
mortality, a systematic review and analysis of the preva-
lence of MNM, based on the new definition, were pub-
lished in 2012 [106]. The results of the meta-analysis
yielded MNM prevalence estimates of 0.42% for organ
dysfunction and 0.039% for emergency hysterectomy.
WHO then initiated a five-year project (2012–2017),
starting with the formation of the Maternal Morbidity
Working Group (MMWG) of global experts. The group
worked to systematically to explore the meaning of
maternal morbidity and ‘examined in depth how best to
define, describe, and measure it for the purposes of
research, epidemiology, and ultimately to improve
women’s experience of the care they receive’ [107]. In
2016, the group published a definition of maternal mor-
bidity (see Box 1) and a matrix of 121 conditions [5],
and in 2018 published a special supplement of the Inter-
national Journal of Gynecology & Obstetrics [108],
describing the formative findings of the project and how
maternal morbidity is necessarily reconceptualised to
describe the experiences of women, and the implications
for health systems and policy.
In a systematic review of systematic reviews by Gon
et al. in the 2018 special issue, for 71% of the 121 listed
morbidities, no systematic review was found, including
for some very serious conditions. Based on the available
data, global estimates were presented for direct maternal
morbidities, including post-partum haemorrhage 6–11%,
preeclampsia 2.3%, severe complications of unsafe abor-
tion 0.6%, eclampsia 0.5% and regional estimates for
gestational diabetes mellitus (5.1% in Africa and 25.1%
in the Western Pacific Region). Estimates of indirect
maternal morbidities included obstetric fistula in LMICs
0–1.6% of post-partum women, post-partum depression
in LMICs 1–50%, anxiety during pregnancy 4.4–39%
worldwide, post-partum anxiety 8.5% worldwide, pooled
HIV incidence rate in sub-Saharan Africa at 4.7 per 100
person-years during pregnancy and 2.9 per 100 person-
years during the post-partum period, syphilis in preg-
nancy in LMICs 0.5-8.3%, chlamydia in pregnancy in
LMICs 0.4–16.4%, malaria during pregnancy 29.5% in
East and Central Africa and 35.1% in West and Central
Africa, and a median of 4.3% of pregnancies are diag-
nosed with seroprevalence of hepatitis B serum antigen
(HBsAg), and between 2.5% and 3.0% of pregnant
women in Africa are infected with hepatitis C [109].
The Child Health Epidemiology Reference Group
(CHERG), a group of independent technical experts
established by WHO in 2001 (now known as the Mater-
nal and Child Epidemiology Estimation Group [MCEE]),
undertook research on maternal morbidity, mainly to
estimate the burden of related diseases and sequelae.
They noted that the causal pattern of morbidity is differ-
ent from that of mortality, and that information on mor-
bidity could have implications for the prioritisation of
safer motherhood interventions [110].
There is still much work to be done before maternal
morbidity can be accurately measured and monitored,
and clear global or national targets set for its reduction.
Currently, MNM cases and MNM ratios are not widely
reported (see Box 2).
Neonatal morbidity
There is as yet no agreed definition or global indicator
for neonatal morbidity, although this was a priority area
as identified in the ENAP Measurement Improvement
Roadmap [98]. Low birthweight (LBW: < 2500 g; see
Box 2) has been used as a marker for babies at highest
risk for neonatal morbidity, as described by Lawn et al.
[80]. LBW or small size at birth ‘is the biggest risk factor
for more than 80% of neonatal deaths and increases risk
of post-neonatal mortality, growth failure, and adult-on-
set non-communicable diseases’ and small babies also
face the highest risk of death in utero [80]. Further avail-
able information on neonatal morbidities is provided in
that report.
In 2002, the United Nations General Assembly Special
Session on Children adopted the goal of reducing the rate
of LBW by at least one-third between 2000 and 2010 as
part of the Declaration and Plan of Action, ‘A World Fit
for Children’ [111]. In 2004, a UNICEF and WHO
report on LBW estimated that more than 20 million
LBW infants were born worldwide in 2000 (15.5% of all
births) [112], providing a baseline for monitoring. Global
estimates published in 2019 indicate that in 2015, 14.6%
(an estimated 20.5 million; 91% of those in low- and
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middle-income countries) of live births were LBW, com-
pared with 17.5% (22.9 million) in 2000 [113].
In 2012, as part of WHO’s ‘Comprehensive implemen-
tation plan on maternal, infant and young child nutri-
tion’, a new target was set to reduce LBW by 30% by
2025, compared with baseline country-level data for
2006–2010 [114]. An article in The Lancet Every New-
born Series (2014) described the challenges of measuring
and achieving this goal, and pointed out that data gaps
for morbidity and coverage and quality of care hindered
efforts to plan programmes and track progress [80].
Also in 2012, Born too soon: the global action report
on pre-term birth was published, presenting the first ever
national, regional and global estimates of pre-term birth.
Globally, in 2010, the pre-term birth rate was 11.1% of
live births; 15 million babies were born pre-term (before
37 weeks’ gestation) and 1 million died from related
complications. The pre-term birth rate in the poorest
countries (12–13%) was substantially higher than high-
income countries (7–9%) [9]. The latest estimates for the
year 2014 (14.8 million pre-term births) now put the glo-
bal pre-term birth rate at 10.6% (ranging from 13.4% in
North Africa to 8.7% in Europe) [115], indicating no sig-
nificant improvement since 2010.
The way forward: aligning monitoring approaches
and closing data gaps for improved maternal and
newborn survival, health and well-being
The often-quoted phrase ‘What gets measured gets done’
encapsulates the relationship between measurement and
action, which also underlines the reason for the focus of
this review on the measurement and monitoring of mater-
nal and neonatal mortality and morbidity and stillbirths
over the past few decades – the ultimate focus is firmly
on improving survival, health and well-being.
Despite major global efforts to develop MNCH targets
and indicators and improve data collection and estima-
tion methods since the 1980s (see Figure 1), and espe-
cially around the start of the MDG era, and again just
before the start of the SDGs, there are still major data
gaps, particularly in countries with the highest burden of
mortality and morbidity and with poor routine health
management information systems and limited CRVS sys-
tems. Global, regional and national estimates are now
available for MMR, NMR and SBR, with modelling
methods employed to enable international comparison
and to provide estimates, including for countries with lit-
tle or no data. But further improvements to the data sets,
disaggregated analyses of these data, and refinements of
the modelling methods are all vital for continued close
monitoring of progress, and improved programming. The
crucial missing pieces at this stage lie in the areas of
maternal and neonatal morbidity; without good, widely
used indicators for these, we will continue to lack an
accurate picture of the burden of disease.
In September 2015, the SDGs were launched, including
SDG 3 – to ensure healthy lives and promote well-being
for all at all ages [116]. The 2016 Indicator and monitor-
ing framework for the Global Strategy for Women’s,
Children’s and Adolescents’ Health, which is aligned with
and builds upon the SDG 3 targets and time frame, set
MMR, U5MR, NMR, SBR and adolescent mortality rate
as its five key indicators for the Global Strategy’s ‘sur-
vive’ objective, but none of its ‘thrive’ indicators have
direct relevance to maternal or newborn morbidity [15].
Countdown to 2030 was launched to accelerate
momentum to achieve the SDG targets for improved
MNCH and to support the renewed Global Strategy
[117]. Some of the suggestions for improvement in the
SDG era, acknowledged in the 2015 Countdown report,
include the following: establish a better set of baseline
data than was available for the MDGs; improve data col-
lection, measurement and estimation methods, especially
for maternal mortality (and add data on stillbirths); use
common (international) standards of measurement and
reporting; and select indicators carefully for validity and
reliability [63].
The SDG target of a global MMR below 70 maternal
deaths per 100,000 live births will require countries to
reduce their MMRs by at least an average of 6.1% each
year between 2016 and 2030 [1], a much greater rate
than the 2.3% average annual rate of reduction achieved
during the MDG era [20]. This is an enormous challenge,
especially when accurate measurement remains problem-
atic and many deaths still go uncounted. To save new-
born lives and prevent stillbirths in the coming years,
Darmstadt et al. have called for greater focus ‘on improv-
ing coverage, quality and equity of care at birth – partic-
ularly obstetric care during labour and childbirth, and
care for small and sick newborns, which gives a triple
return on investment’ in terms of maternal and newborn
lives and stillbirths. The authors also emphasise that pro-
gress will depend on political prioritisation for newborn
lives (and for ENAP implementation), which becomes
more likely when we can disseminate ‘credible data on
levels of burden and intervention uptake’ [88].
Conclusions
This review has featured the long story of the progress in
monitoring improving MNH outcomes, but has also
underlined current gaps and significant inequities. The
many global initiatives described in this paper have
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highlighted the magnitude of the problems and have built
the political momentum over the years for effectively
addressing maternal and newborn health and well-being,
with particular focus on improved measurement and
monitoring. Although substantial reductions in mortality
have been achieved, the enormous maternal and newborn
health disparities that persist between low- and high-in-
come countries, and within countries, show that in the
SDG era there is still an urgent need to renew the focus
on reducing inequities and dedicate more resources to
these efforts. We must scale up evidence-based and
human rights-based initiatives that work to improve the
safety of pregnancy, childbirth, and the neonatal and
post-partum periods.
The relevant SDG targets focus mainly on mortality
reduction, but other measures are needed to capture
related issues such as coverage and quality of care. And
for all the MNH outcomes discussed, we still depend
on estimates, as reliable data are still not collected or
made available on a regular or frequent basis in many
countries. In addition, the changing epidemiology of
maternal mortality (with implications also for neonatal
mortality and stillbirths, and maternal and neonatal
morbidity) has been described by Souza et al. as the
obstetric transition [118]. With increasing coverage of
health services such as skilled birth attendants and insti-
tutional delivery, and associated changes in the epidemi-
ology of the outcomes, there is a need to modify
measurement and monitoring to be aligned with new
priorities.
While this was not the focus of this review, clearly
further work is needed to prioritise and harmonise mea-
sures of coverage and quality of care. MoNITOR is
working to address the measurement and monitoring
issues, as are other partners such as the Lancet Global
Health Commission on High Quality Health Systems in
the SDG Era (HQSS Commission) [119] and WHO’s
Quality, Equity, Dignity Network [120]. Equally, with
the Global Strategy focus on ‘survive, thrive and trans-
form’, there is an urgent need to identify and test mea-
sures of morbidity for women and newborns. Ongoing
work by WHO and others is a good start, but it needs
to be prioritised – especially the development of indica-
tors that can be routinely measured within existing sys-
tems.
Finally, monitoring progress requires strong informa-
tion systems to assess different types of indicators. Cur-
rently, we rely primarily on population-based surveys
conducted every two to five years (Appendix 1) and spe-
cial studies to measure mortality and cause of death espe-
cially in low- and middle-income countries (Appendix 2).
These surveys and studies are essential, but there is also a
need for countries and donor agencies to invest in
improving routine health management information sys-
tems and CRVS systems, including improvements to the
availability, quality (accuracy), timeliness and the analysis
and use of these data. These recommendations will ulti-
mately lead to monitoring and measurement of what
matters to improve maternal and neonatal survival,
health and well-being.
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Appendix 1
Population-based household surveys
gathering data to measure and
monitormaternal, newborn and child health
These surveys have contributed data to national and glo-
bal efforts to monitor the health and well-being of
women and children, including a proportion of them
which have reported on maternal and neonatal mortality.
World Fertility Surveys (WFS):
When: Surveys conducted 1974–1983; programme
ended in 1987
What: Nationally representative surveys of reproduc-
tive health and household characteristics, most including
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both a household and individual (female) component,
often including additional topics such as water, sanita-
tion, mortality, or economic status
Where: 42 surveys in 41 low-income countries, and 20
in high-income countries (adapted version)
Established: International Statistical Institute (ISI), the
Netherlands
Funded: United States Agency for International Devel-
opment (USAID), United Nations Population Fund
(UNFPA) and UK Overseas Development Administration
Implemented: National agencies, often the statistical
office
Comment on data use: Scientific reports published by
the WFS included data on infant, child and adult mortal-
ity.
Sources: The DHS Program (https://wfs.dhsprogram.c
om/); Global Health Data Exchange (http://ghdx.healthda
ta.org/series/world-fertility-survey-wfs).
Demographic and Health Surveys (DHS):
When: Surveys conducted 1984–present
What: Nationally representative surveys of population,
health (including vaccination, treatment and prevalence
of illnesses), nutrition, mortality and demographic char-
acteristics, aiming to be repeated every five years in each
country, with smaller surveys in between; the maternal
mortality module was added in 1988, the year after the
launch of the Safe Motherhood Initiative, and has since
been implemented in 60 countries
Where: More than 300 surveys in over 90 countries
Developed and funded: USAID
Implemented: ICF International and partners (previ-
ously by Macro International, until 2009)
Comment on data use: Child, infant and neonatal
mortality are routinely reported. Although data on
maternal mortality are not collected in every survey,
DHS have always been the main data source for esti-
mation of maternal mortality in developing countries.
The data are gathered using the direct sisterhood
method (see Appendix 2), and then, maternal mortality
ratios (MMRs) are calculated. These data (along with
data from RHS for some countries, see below) have
been used by the UN Maternal Mortality Estimation
Inter-agency Group (MMEIG) to track trends in
MMRs since 1990 (see Tables 2 and 3). However,
underestimation of MMR using DHS data remains a
challenge.
Sources: The DHS Program (https://dhsprogram.com/);
Ahmed et al. ICF International, 2014 [121].
Reproductive Health Surveys (RHS):
When: Surveys conducted 1992–present
What: Surveys on topics including fertility, family plan-
ning, infant and child mortality, maternal and child
health (including pregnancy, delivery and post-partum
care), birthweight, immunisation, breastfeeding, HIV/
AIDS, adolescent and young adult sexuality, and general
health practices; selected surveys have also included infor-
mation on abortion, STIs, anthropometric measures,
anaemia, violence against women, maternal mortality,
maternal morbidity
Where: A few dozen RHS have been conducted, in
countries in Latin America and the Caribbean, Africa,
and eastern Europe/western Asia
Established: The U.S. Centers for Disease Control and
Prevention (CDC) Division of Reproductive Health,
through an agreement with USAID, established the Con-
traceptive Prevalence Survey (CPS) in 1975, which
became the Maternal and Child Health/Family Planning
(MCH/FP) Survey in the early 1980s before including
additional reproductive health issues to the survey, which
was then renamed as the RHS in the late 1980s
Funded: USAID
Implemented: Ministries of health and other partners,
with technical assistance from CDC’s Division of Repro-
ductive Health; the questionnaires are adapted for each
country’s data requirements
Comment on data use: While the questions are similar
to those in the DHS, the data have not been recoded into
a standardised format. Data from RHS have been used
along with DHS data for global maternal mortality esti-
mation.
Sources: Global Health Data Exchange (http://ghdx.hea
lthdata.org/series/reproductive-health-survey-rhs); Ahmed
et al.; ICF International, 2014 [121].
Multiple Indicator Cluster Surveys (MICS):
When: Surveys conducted 1995–present; since 2009
countries are supported to conduct surveys every 3 years
instead of every 5 years
What: Nationally representative household surveys,
conducted in rounds (currently on round 6, which was
launched in 2016, to provide baseline data for the SDGs);
MICS generate data with an emphasis on maternal and
child health indicators, which include infant and under-
five mortality rates, MMR and per cent of deliveries with
a skilled attendant
Where: Over 300 MICS have been carried out in more
than 100 countries
Established: UNICEF established MICS in response to
the World Summit on Children (1990) and the global
goals agreed at that time
Funded: UNICEF and partners provide financial assis-
tance
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Implemented by Implementing agencies (usually gov-
ernment agencies) customise the selected modules of the
standard MICS questionnaires (designed by UNICEF) to
the national setting, and implement the surveys (technical
support is provided throughout by UNICEF and its MICS
experts)
Comment on data use: MICS was a source of data on
MDG indicators and will continue to be a source of data
for SDGs. When maternal mortality data are collected,
the direct sisterhood (sibling history) method is used, as
for the DHS.
Source: UNICEF, 2018 (http://mics.unicef.org/); UNI-
CEF, 2014 (https://www.unicef.org/statistics/index_
24302.html).
General note regarding survey data on maternal mor-
tality:
As noted in the 2015 WHO report on maternal mortal-
ity trends, ‘Specialised studies indicate that there is some
underreporting of maternal or pregnancy-related deaths
in PMs [the proportion of deaths among women of
reproductive age that are due to maternal causes] derived
from sources such as population-based surveys, censuses
and surveillance systems, particularly since respondents
may be unaware of the pregnancy status of their sisters
or other women in the household’. The estimates often
have to be adjusted upwards for underreporting and/or
downwards to exclude incidental/accidental deaths, and
there may also be sampling errors, and errors occurring
during data collection, management and analysis (WHO,
2015 and 2019) [20,1].
Appendix 2
Challenges and advances in the measurement
of maternal mortality
Due to a range of complexities, maternal mortality has
been extremely challenging to measure accurately. Until
the late 1980s, estimates of national and regional
maternal mortality levels for low-income countries were
extrapolated from relatively small studies, mostly using
hospital data (i.e. not representative of the general pop-
ulation), while for high-income countries with civil reg-
istration systems in place, more accurate data were
available earlier. With the setting of global goals
(MDG Target 5.A and now SGD Target 3.1, see
Table 1), all countries have needed to measure mater-
nal mortality so that national and regional levels of
MMR can be estimated and monitored to assess pro-
gress (see Appendix 1), and sub-national estimates are
also needed as a basis for more effective programming
and policies. The measurement methods and quality of
data sources for the estimation of maternal mortality
have evolved somewhat over time, but there remain
many challenges in most low- and middle-income coun-
tries.
Civil registration and vital statistics (CRVS)
In general, CRVS systems are the preferred data source
and considered to be the gold standard for mortality data
[1]. Ideally, all maternal and newborn deaths and still-
births (along with all other deaths as well as births,
adoptions, marriages, divorces, etc.) in a country should
be recorded in the national CRVS system. The record of
each death should include the age and sex of the
deceased, as well as the cause of death, based on a medi-
cal certificate completed by a physician. Documentation
of cause of death requires close collaboration between
the CRVS system and the health sector. However, there
is wide variation among countries and sometimes within
countries (e.g. between provinces or states with adminis-
trative autonomy) in how CRVS systems are structured
and how well they function. Some countries lack a CRVS
system that is nationally representative, or any CRVS
system at all, while others fail to enforce the reporting of
all deaths (resulting in incomplete CRVS) and/or have
high levels of misclassification of cause of death, and
these reporting errors are especially likely to affect
maternal and neonatal deaths, foetal deaths and
stillbirths.
Specialised and community-based studies
In the absence of a well functioning national CRVS
system, many countries conduct specialised studies on
maternal mortality, which are a helpful contribution to
the estimation of national MMR. The task in conducting
such studies is to compile accurate data on maternal
deaths in a specified time period from a sample of living
respondents (i.e. relatives of each deceased woman) that
is large and representative enough to support a statisti-
cally reliable estimate of the frequency of this relatively
rare (e.g. compared to infant or child deaths) and often
sensitive or stigmatised event. Population-based house-
hold surveys require unfeasibly large sample sizes if they
are to obtain statistically reliable estimates of maternal
deaths by directly interviewing respondents (direct esti-
mation), and therefore they are not cost-effective. The
use of estimates with wide confidence intervals is rela-
tively meaningless and can lead to misinterpretations of
differences between locations or progress between two
time points [122]. Therefore, the methods for collecting
data and measuring maternal deaths using community-
based studies have evolved over time and are still being
refined.
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The first published community-based studies on mater-
nal mortality in low-income countries were published in
1986 and 1988. One, by Kwast et al. (1986), reported on
a probability survey using a two-stage stratified sample to
obtain a geographically representative sample in Addis
Ababa, Ethiopia (1981–83), reporting an MMR of 566
per 100,000 live births for 1982–83, based on visits to
32,215 selected houses [123]. The other, by Fortney et al.
(1988), was the Reproductive Age Mortality Survey
(RAMOS) conducted in Menoufia, Egypt (1981–83) and
Bali, Indonesia (1989–82), reporting MMRs of 190 and
718, respectively, among other measures [124]. The
RAMOS method involves first compiling a list of deaths
to women of reproductive age, either from a CVRS sys-
tem (as in Menoufia) or from local leaders and commu-
nity health workers (as in Bali), and then interviewing
surviving family members (and supplementing this with
information from physicians/hospitals if possible) and
finally having this information reviewed by physicians to
establish the cause of death. Adjustments are required in
the later calculations since the lists of deaths will not be
complete. The methods used for these and other studies,
however, have serious limitations, and in general retro-
spective studies lead to underestimation, and prospective
studies – for a relatively rare event like maternal death –
are too large and costly [125].
The sisterhood method
In 1989, Wendy Graham and colleagues introduced the
sisterhood method, ‘a new, indirect technique for deriving
population-based estimates of maternal mortality’ [126],
an innovation which has been recognised as a key mile-
stone on the road to more accurate measurement of this
challenging indicator. The sisterhood method was
designed to better measure maternal mortality without
requiring such large sample sizes and thus it reduces
costs, but it is only appropriate for use in settings with
high TFR (3 +) and high maternal mortality. The major
disadvantage of the indirect sisterhood method is that the
results reflect a time point 10–12 years in the past [122].
With this method, all adults (age 15 +) in selected areas
are asked to report how many of their ever-married sis-
ters (born to the same mother) were alive and how many
were dead, and of the latter how many had ‘died while
they were pregnant, or during childbirth, or during the
six weeks after the end of pregnancy’; the resulting data
are used to derive the lifetime risk of maternal death,
which can be translated to an MMR. These questions
can be included in a multi-purpose household survey or
census [126]. The sisterhood method has since been
revised and refined, as indeed was anticipated in the orig-
inal publication. A ‘direct sisterhood method’ variant
yields estimates for a more recent time point 3–4 years
before the survey, but requires the use of more questions
and also a larger sample size. The DHS and MICS both
use the direct variant (for more information on the DHS
and MICS, see Appendix 1). As written in 1997 about
the sisterhood method, ‘Both methods provide estimates
of maternal mortality that should be seen as giving orders
of magnitude rather than precise ratios since both can
have wide margins of error (wide confidence intervals).
Neither method provides a current estimate for the year
of the survey. For these reasons, sisterhood studies cannot
be used to monitor changes in maternal mortality nor to
assess the impact of safe motherhood programmes in the
short term’ [122]. According to Stanton et al. (2000),
‘The sampling errors associated with maternal mortality
ratios are substantially larger than those associated with
other frequently used DHS indicators. This lack of preci-
sion precludes the use of these data for trend analysis
and has led to the recommendation that this DHS module
not be used more than once every ten years in the same
country’ [127]. Nevertheless, DHS data, collected using
the direct sisterhood method, are used as a basis for esti-
mation and monitoring of global MMR (using modelling
techniques) by the UN MMEIG and the Institute for
Health Metrics and Evaluation(IHME), for lack of any
better data source (i.e. a good CRVS system) in many
countries [128]. The Initiative for Maternal Mortality
Programme Assessment (IMMPACT), established in 2002
under the direction of Wendy Graham, worked on
(among other things) the development of new ways of
measuring maternal mortality, and related tools and tech-
niques, and also developed the Maternal Mortality Mea-
surement Resource (MMM-R) – a web-based collection
of information, materials and tools (www.maternal-
mortality-measurement.org.uk/) [129].
Maternal death surveillance and response (MDSR)
MDSR offers a method for obtaining more complete
information on maternal deaths in ‘real time’ and could
support better MMR estimation and stimulate more
timely response and action to prevent future deaths
[130]. In 2013, WHO and partners issued technical guid-
ance on MDSR [131] ‘a continuous action cycle’ that
builds on the maternal death review (MDR) approach.
MDR, both community- and facility-based, was described
by WHO in 2004 in Beyond the numbers: reviewing
maternal deaths and complications to make pregnancy
safer [132]. An effective MDSR system requires that
maternal deaths be made a notifiable event, among others
(e.g. cases of notifiable diseases). Notifications (of mater-
nal deaths in healthcare facilities and communities)
would be followed by a review to assess contributing
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factors and avoidability – the results of these district-level
reviews feed into national-level analysis, leading to rec-
ommendations for further action, and finally response
(implementation of recommendations) [131]. In countries
lacking national CRVS systems, MDSR can serve as ‘a
building block for a comprehensive, national-level data
collection system’[1]. Since the publication of the techni-
cal guidance, MDSR has become more widely established
globally and it is integral to the WHO Quality of Care
initiative, the Global Strategy on Women’s, Children’s
and Adolescents’ Health, the Ending Preventable Mater-
nal Mortality (EPMM) strategy and the Every Newborn
Action Plan (ENAP); its uptake and implementation are
being studied, with surveys every two years and there is
optimism it will contribute to eliminating preventable
maternal mortality [133].WHO convenes a global techni-
cal working group (TWG) on MDSR, which was estab-
lished in 2015, involving key global partners including
UNFPA and UNICEF. In November 2017, this global
TWG was re-launched to include perinatal audit, hence
MDSR changed to MPDSR (maternal and perinatal death
surveillance and response), with the aim to catalyse pro-
gress and improve MPDSR implementation globally.
Confidential enquiry into maternal death (CEMD)
CEMD was also described in WHO’s 2004 publica-
tion, Beyond the numbers, defined as ‘a systematic multi-
disciplinary anonymous investigation of all or a
representative sample of maternal deaths occurring at an
area, regional (state) or national level which identifies the
numbers, causes and avoidable or remediable factors
associated with them’[131]. CEMD can be used to facili-
tate investigation and correction of both incompleteness
and misclassification in the CRVS system, with regard to
maternal deaths [1]. It involves detailed expert review of
all potential maternal mortality cases among women of
reproductive age, to assess the accuracy of classification
and to examine the circumstances of the death, thus iden-
tifying areas for action to prevent future deaths. CEMD
was developed in England and Wales, where it is still
used, and studies of CEMD have been conducted in a
number of other countries, such as Australia, France, Ire-
land, Mexico and New Zealand [1].
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